Milestone Pharmaceuticals (MIST) Net Equity Issued and Repurchased (2020 - 2026)
Milestone Pharmaceuticals (MIST) posted Net Equity Issued and Repurchased of $10.9 million for Q1 2026, down 24.64% on a QoQ basis from $14.4 million in Q4 2025.
Milestone Pharmaceuticals (MIST) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $10.9 million for Q1 2026.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $10.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (changed N/A YoY) and the FY2025 annual result came in at $37.6 million, up 37.92% from the prior year.
- Net Equity Issued and Repurchased was $10.9 million for Q1 2026 at Milestone Pharmaceuticals, down from $14.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $27.5 million in Q1 2024 and bottomed at -$280000.0 in Q2 2024.
- A 4-year average of $10.5 million and a median of $10.9 million in 2026 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 10.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.89 Mn |
| Mar 31, 2026 | 10.89 Mn |
| Dec 31, 2025 | 14.45 Mn |
| Dec 31, 2025 | 14.45 Mn |
| Jun 30, 2024 | -280,000.00 |
| Jun 30, 2024 | -280,000.00 |
| Mar 31, 2024 | 27.54 Mn |
| Mar 31, 2024 | 27.54 Mn |
| Dec 31, 2022 | -14,000.00 |
| Dec 31, 2022 | -14,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Mar 31, 2020 | 77,000.00 |
| Mar 31, 2020 | 77,000.00 |